Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11)

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 171-176

  Hirao, Koichi ^a   Arai, Keiko ^b   Yamauchi, Mikio ^a   Takagi, Hirofumi ^c   Kobayashi, Masashi ^d  

^a HEC Science Clinic   (Japan)

^b Arai Clinic   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Biphasic insulin aspart 30; Insulin aspart; Randomized trial; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DERIVATIVE; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DIET; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN TREATMENT; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; JAPAN; MALE; MIDDLE AGED; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 37549055035     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.08.011     Document Type: Article

References (19)

1. The Diabetes Control Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
2. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
3. Small M., MacRury S., Boal A., Paterson K.R., and MacCuish A.C. Comparison of conventional twice-daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen™) in insulin-dependent diabetes mellitus. Diabetes Res. 8 (1988) 85-89
4. Yki-Jarbinen H., Kauppila M., Kujansuu E., Lahti K., Marjanen T., Niskanen L., et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 327 (1998) 1426-1433
5. Kobayashi M., Yamazaki K., Hirao K., Oishi M., Kanatsuka A., Yamauchi M., et al. The status of diabetes control and antidiabetic drug therapy in Japan-A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1). Diabetes Res. Clin. Pract. 73 (2006) 198-204
6. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi T., et al. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res. Clin. Pract. 55 (2002) 65-85
7. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes provisional report of a WHO consultation. Diabetic Med. 15 (1998) 539-553
8. Home P.D., Lindholm A., Riist A., and European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial. Diabetic Med. 17 (2000) 762-770
9. Raskin P., Riis A., Guthrie R.A., Jovanovic L., and Leiter L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 23 (2000) 583-588
10. Brange J., and Volund A. Insulin analogs with improved pharmacokinetic profiles. Adv. Drug Deliv. Rev. 35 (1999) 307-335
11. Jorgensen L.N., and Nielsen F.S. Timing of pre-meal insulin in diabetic patients on a multiple daily injection regimen. A questionnaire study. Diabetologia 33 (1990) A116
12. Boehm B.O., Home O.D., Behrend C., Kamp N.M., and Lindholm A. Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients. Diabetic Med. 19 (2002) 393-399
13. UKPDS 33, Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes, Lancet 352 (1998) 837-853.
14. Levy J., Atkinson A.B., Bell P.M., McCance D.R., and Hadden D.R. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabetic Med. 15 (1998) 290-296
15. Mandrup-Poulsen T. Beta-cell apoptosis, stimuli and signaling. Diabetes 50 Suppl. 1 (2001) S58-S63
16. Rachman J., Payne M.J., Levy J.C., Barrow B.A., Holman R.R., and Turner R.C. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM. Diabetes Care 21 (1998) 810-816
17. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto M.W., Ensinck J.W., Tarborsky Jr. G.J., et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cell. Diabetes 39 (1990) 634-638
18. The Diabetes Control and Complication Trial Research Group, Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complication Trial. A randomized, controlled trial, Ann. Intern. Med. 128 (1998) 517-523.
19. Ilkova H., Glaser B., Tunckale A., Bagriacik N., and Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by intensive insulin treatment. Diabetes Care 9 (1997) 1353-1356